Genetic engineering of antiviral agents.

doi:10.1128/aac.31.9.1293

Genetic engineering of antiviral agents.

Antimicrobial Agents and Chemotherapy

A S Huang, J Böni

Abstract

No abstract listed.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M L Stephenson, P C Zamecnik

Jul 20, 1978·Nature·T TaniguchiC Weissmann

Oct 5, 1986·Nature·J C BurnsD Y Leung

Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P SarnowD Baltimore

May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C C SmithP O Ts'o

Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P C ZamecnikP S Sarin

Dec 1, 1986·Journal of Virology·H D BernsteinD Baltimore

Jan 1, 1986·Progress in Nucleic Acid Research and Molecular Biology·C Weissmann, H Weber

Jan 17, 1986·Cell·R LevisS Schlesinger

Mar 1, 1985·Virology·A Jalanko, H Söderlund

Oct 22, 1985·Biochemistry·K R BlakeP S Miller

Jan 1, 1973·Annual Review of Microbiology·A S Huang

Aug 1, 1984·Journal of Virology·M SchubertE Meier

Nov 20, 1981·Science·V R Racaniello, D Baltimore

Aug 25, 1983·Nucleic Acids Research·H Weber, C Weissmann

Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D PanicaliE Paoletti

Apr 7, 1983·Nature·G L SmithB Moss

Genetic engineering of antiviral agents.

Abstract

References

Related Concepts

Related Feeds

Related Papers

Genetic engineering of antiviral agents.

Abstract

References

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

QB DNA-containing hybrid plasmids giving rise to QB phage formation in the bacterial host

Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease

A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome.

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Genetic complementation among poliovirus mutants derived from an infectious cDNA clone.

The interferon genes

Deletion mapping of Sindbis virus DI RNAs derived from cDNAs defines the sequences essential for replication and packaging

The repeated regions of Semliki Forest virus defective-inferfering RNA interferes with the encapsidation process of the standard virus

Hybridization arrest of globin synthesis in rabbit reticulocyte lysates and cells by oligodeoxyribonucleoside methylphosphonates

Defective interfering viruses

Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations

Cloned poliovirus complementary DNA is infectious in mammalian cells

Formation of genes coding for hybrid proteins by recombination between related, cloned genes in E. coli

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals

CRISPR Screens in Drug Resistance

Related Papers

Absence of reverse transcriptase activity in cultured peripheral blood mononuclear cells from patients with systemic-onset juvenile rheumatoid arthritis

Deletion mapping of Sindbis virus DI RNAs derived from cDNAs defines the sequences essential for replication and packaging

alpha-Oligodeoxynucleotide stability in serum, subcellular extracts and culture media

Infectious RNA derived by transcription from cloned cDNA copies of the genomic RNA of an insect virus

Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome.